EDGAR Filing Documents for 0001193125-23-080536

Form 8-K - Current report:

SEC Accession No. 0001193125-23-080536

Filing Date

2023-03-27

Accepted

2023-03-27 16:44:29

Documents

Period of Report

2023-03-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d422544d8k.htm iXBRL	8-K	50916
2	EX-3.1	d422544dex31.htm	EX-3.1	105882
3	EX-4.2	d422544dex42.htm	EX-4.2	81438
4	EX-10.1	d422544dex101.htm	EX-10.1	198215
5	EX-10.2	d422544dex102.htm	EX-10.2	131586
6	EX-99.1	d422544dex991.htm	EX-99.1	67844
10	GRAPHIC	g422544harpoon.jpg	GRAPHIC	10428
	Complete submission text file	0001193125-23-080536.txt		917842

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	harp-20230322.xsd	EX-101.SCH	2857
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	harp-20230322_lab.xml	EX-101.LAB	19483
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	harp-20230322_pre.xml	EX-101.PRE	12158
12	EXTRACTED XBRL INSTANCE DOCUMENT	d422544d8k_htm.xml	XML	3693

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080

Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400

Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)